Provention Bio's TZIELD (teplizumab-mzwv) Receives the US FDA's Approval of BLA for the Treatment of Stage 2 Type 1 Diabetes
November 21, 2022
Provention Bio Initiates P-IIa (PREVAIL-2) Study of PRV-3279 for the Treatment of Systemic Lupus Erythematosus
January 21, 2022
PharmaShots Weekly Snapshots (May 24 - 28, 2021)
May 28, 2021
PharmaShots Weekly Snapshot (January 4-8, 2020)
January 8, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.